EUVIMED · CrossrefZeitschrift
Hematology in Clinical Practice
ISSN 2720-2690 · VM Media Group sp. z o.o
Neueste Artikel
Critical airway narrowing in the course of lymphoblastic lymphoma in an 11-year-old: a case report
Cutaneous Rosai–Dorfman disease: a comprehensive literature review and two case reports
Diagnostic and therapeutic recommendations of the Polish Society of Haematologists and Transfusiologists and Polish Adult Leukemia Group-CLL for chronic lymphocytic leukemia in 2021
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) — diagnostic and therapeutic challenge
Efficacy of lenalidomide in the treatment of myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U) with the presence of deletion 5q– and trisomy 8+
Secondary immune thrombocytopenia after Streptococcus infection
Ponatinib in treatment of chronic myeloid leukemia with T315I mutation
Tranexamic acid for traumatic brain injury? Old drug raises new debate
Polish Experts’ Position Statement on the use of granulocyte colony-stimulating factor in the treatment of chronic lymphocytic leukemia with venetoclax combined with rituximab
The use of midostaurin in the treatment of advanced systemic mastocytosis
The use of midostaurin in aggressive systemic mastocytosis (ASM) with the c-KIT D816V mutation within The Emergency Access to Drug Technologies Programme
Effective midostaurin treatment in a patient with aggressive systemic mastocytosis
Adverse events of monoclonal antibodies use in therapy of hematological malignancies
IGHV mutational status and the choice of first-line therapy for patients with chronic lymphocytic leukaemia
Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features
Treatment of a patient with acute myeloid leukaemia with FLT3-ITD mutation
Midostaurin in the treatment of a patient with acute myeloid leukaemia with FLT3-TKD mutation and NPM1 mutation
Effective treatment of severe forms of RSV and Pneumocystis jirovecii infections in a child with Down syndrome and acute lymphoblastic leukemia treated with chemotherapy
How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?
Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies
Pulmonary embolism after anti-SARS-CoV-2 vaccines in two female patients
Study of type and frequency of Alfa-thalassemia mutations in a cohort of 3,823 patients from Isfahan Province, Iran
Antithrombotic prophylaxis in patients treated with Bruton’s tyrosine kinase inhibitors
How to prevent sinusoidal obstruction syndrome/veno-occlusive disease?
Acute promyelocytic leukemia: from genetic lesions identification to molecularly targeted therapy
JAK and STAT gene mutations and JAK-STAT pathway activation in lympho- and myeloproliferative neoplasms
Polyserositis (pericarditis and bilateral pleural effusion) after COVID-19 mRNA vaccine
Hematological manifestations of X-linked lymphoproliferative disease
Burkitt-like lymphoma with 11q aberration mimicking appendicitis in a young man — a diagnostic and therapeutic challenge
Plasmablastic lymphoma in an HIV-negative patient with complete remission after chemotherapy with DA-EPOCH
EUVIMED